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ABSTRACT 
 A series of twelve anionic, cationic, and neutral nickel (II) complexes have been synthesized 
and characterized. The interaction of these complexes with bovine serum albumin (BSA), human 
serum albumin (HSA), lysozyme (Lyso), and tryptophan (Trp) has been studied using steady-state 
fluorescence spectroscopy.  Dynamic and static quenching constants have been calculated, and the 
role played in quenching by the ligand and complex charge investigated. The nickel complexes 
showed selectivity towards the different proteins based on the environment surrounding the Trp 
residue(s). Only small neutral complexes with hydrophobic ligands effectively quenched protein 
fluorescence via static quenching, with association constants ranging from 102 M-1 (free Trp) to 1010 
M-1 (lysozyme), indicating a spontaneous and thermodynamically favorable interaction. The number 
of binding sites, on average, was determined to be one in BSA, HSA and free Trp, and two in 
lysozyme. 
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INTRODUCTION 
Protein interactions play a fundamental role in many biochemical processes in both the healthy and 
the diseased state, including critical roles in signal transduction, immune reaction, cell cycle control, 
differentiation, and protein folding. In order to understand, probe and manipulate biological systems 
effectively there is a need to develop small molecules that influence or inhibit protein interactions 
through selective recognition.1,2 Small metal complexes can potentially combine flexibility in ligand 
design with access to a wide and diverse range of coordination geometries, optical isomers and 
electronic states. This flexibility can be used to enable or prevent coordination of the metal complex 
to protein side chains or substrates.  
a. Serum Proteins: Several different transport proteins exist in blood plasma, but only albumin is 
able to bind and transport a wide diversity3-6 of ligands with reversibility and high affinity. For many 
drugs, binding to serum albumin is a critical determinant of their distribution and pharmacokinetics.7-
9 HSA accounts for 60% of the measured serum proteins, thus one of the most abundant proteins in 
the circulatory system.10-13 HSA consists of a single polypeptide chain of 585 amino acids, a scarcity 
of Trp and Met residues, and an abundance of Cys and charged residues.14-17 BSA is a homologous 
globular protein, consisting of 583 amino acid residues in the mature form, the sequence of BSA is 
76% identical to that of HSA. While the crystal structure of HSA as well as its binding with fatty 
acids has been characterized, the crystallographic structure of BSA has not been determined to any 
sufficient resolution.16-19 The albumins are composed of three structurally similar domains (I, II and 
III), each containing two subdomains (A and B) and stabilized by 17 disulphide bridges.11-15,20-24 The 
flexible multidomain structures house a variety of binding sites, and allows for cooperativity and 
allosteric modulation, thus making HSA and BSA similar to multimeric proteins.  
Albumins can reversibly bind with a number of molecules in the plasma through various interactions. 
Of the two major structurally selective binding sites, the binding affinity offered by site I is largely 
through hydrophobic interactions, whereas site II involves a combination of hydrophobic, hydrogen 
bonding, and electrostatic interactions.25,26 Most strongly bound are medium‐sized hydrophobic 
organic anions, including long‐chain fatty acids, bilirubin and haematin. Hydrated monovalent cations 
do not associate to any significant extent, whereas hydrated divalent cations such as Ca2+ strongly 
bind at select groups on the albumin molecule.27 Information about the interaction of ions surrounded 
by various types of organic ligands with serum albumin can help reveal the role of albumins in the 
normal state and in the diseased state, and thus provide the basis for the rational-design of efficient 
drugs, sensitizers, and new therapeutic approaches. 
b. Nickel and Metal Binding: Metals have important roles in biological systems ranging from 
essential to toxic, and as such the metal-binding capacity of albumins has been widely studied over 
the years,28-33 including the affinity, stoichiometry and specificity of Ca(II), Co(II), Ni(II), Cu(II), 
Zn(II), Cd(II), Cr(III), V(III), and Mo(VI) ions.34-46 Although there is a lack of detailed structural 
information, four different metal sites have been described, and specificity is achieved by exploiting 
differences in the co-ordination chemistries of the preferred metal ions: (i) ATCUN site (N-terminal 
Cu/Ni-binding) motif at the N-terminus, the primary site47 for Cu(II) and Ni(II); (ii) site A, the 
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primary Zn(II)-binding site6 that can also bind other +2 metal ions; (iii) site B, which displays a high 
affinity towards Cd(II), the location of which is unknown;36,38,40 and (iv) the reduced thiol of Cys-34, 
which binds gold48 and platinum49,50 compounds. 
Nickel enzymes were first discovered51 in the 1970’s, and although studies in rats indicates that Ni is 
an essential element for higher animals,52,53 neither the source of the Ni requirement nor a single 
mammalian Ni-dependent enzyme has been identified. Although pure Ni itself is not toxic, Ni 
complexes can be highly toxic especially with long term contact exposure in humans.54,55 Allergy to 
Ni is a phenomenon which has assumed growing importance in recent years.56 According to current 
models, haptens penetrating the epidermis bind to carrier proteins found just under the skin, leading 
to an inflammatory reaction within the skin.57-63 The role played by albumins in translocating Ni2+ 
toward deeper epidermal layers has not been satisfactorily resolved, though it is of interest that (1) 
HSA is particularly abundant in skin, (2) it is a transporter of essential nutrients for epithelial cells in 
the absence of blood vessels, and (3) it is able to efficiently cross the epidermal basement membrane.64 
The investigation of the interaction of Ni complexes with serum albumins is imperative.   
c. Fluorimetry: One way to measure the extent and accessibility of protein binding sites to small 
molecules involves fluorescence quenching. Information concerning the number of binding sites, the 
binding constant Ka, and the distance between donor and acceptor can be readily obtained using Stern–
Volmer kinetics and Forster’s theory.65-68 The fluorescence signature of a protein derives from the 
aromatic residues. The fluorescence from the indole group in Trp is extremely sensitive to its 
environment, and is a convenient spectroscopic probe for the structure and rotational dynamics 
surrounding the Trp residue.66,69 These Trp residues can undergo electronic excitation in the visible 
region, and the emission can be quenched via different mechanisms depending on the degree of 
“exposure” to the quencher.70,71 Therefore, changes in the intrinsic fluorescence and the bimolecular 
quenching rate constant can be used to monitor structural changes in a protein, and reveal information 
on Trp accessibility and how deep it is buried in the protein.66 In HSA, a Trp residue at position 214 
is buried in the second helix of the second domain, in a hydrophobic fold. BSA has an additional Trp 
in position 131 which is found on the surface of the protein.13  
The interaction of metal ions has led to our interest in studying the interaction of transition metal 
complexes with proteins. The primary focus has been on the effect that different ligand systems have 
on the interaction, particularly the drug-binding sites of BSA. Secondly, the possibility that 
fluorescence quenching of the protein is due to FRET (fluorescence resonance energy transfer) from 
the protein to the complex will lead to the calculation of intermolecular distances to help determine 
the proximity of the complex to the albumin proteins.13 A recent study concerning the interaction of 
a fluorone-Mo(VI) complex with HSA and BSA72 showed strong and significant interactions between 
the metal complex and the protein.73 Others have recently reported that a Cr(III) complex, 
([Cr(salprn)(H2O)2]ClO4), is capable of quenching BSA via FRET leading to a non-specific 
photocleavage of the protein.74,75 We have recently shown that a Cr(III) complex, (R,R)-N,N’-
Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexane-diamino chromium (III), binds very tightly to 
serum albumins and lysozyme, and that the binding is highly specific and the quenching is static in 
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nature and is not due to energy transfer.76 Lysozyme is included in our studies since it is well 
characterized,77-79 and contains multiple Trp residues that are important for enzymatic activity.80 It is 
a single polypeptide chain of 129 amino acid residues, six of which are Trp residues at positions 28, 
62, 63, 108, 111, and 123. The residues at 62, 63, and 108 are located deep in the active site. It is 
expected that each of the residues will be affected differently depending upon their accessibility, and 
thus contributing independently to the inherent fluorescence intensity.71,77,80-83   
In this work, we have studied the interaction between a series of Ni (II) complexes (Figure 1) and 
Lysozyme, HSA and BSA, using fluorescence and UV–vis spectroscopic techniques under 
physiological conditions. The interaction between the Ni (II) complexes and free Trp was also 
investigated to illustrate the affinity of the complex for this particular amino acid residue, irrespective 
of environment. The results have allowed us to discuss the type, degree and nature of the interaction 
and binding between the protein and metal complexes with consideration to polarity, hydrophobicity, 
charge, and spin state of the metal complex. 
 
EXPERIMENTAL 
A. General Procedures 
Unless otherwise mentioned, all chemicals were of analytical reagent grade (Sigma Aldrich or VWR). 
Synthetic procedures and manipulations were conducted using Schlenk techniques, under an Ar 
atmosphere. The solvents were either HPLC-grade or were dried and distilled using conventional84,85 
methods and stored under an Ar atmosphere. All proteins and Trp were purchased from Sigma-
Aldrich and used without further purification. Stock solutions of proteins, Trp and Ni(II) complexes 
were prepared in 50 mM Tris–HCl buffer solution (pH 7.4). Synthesis and characterization data for 
all complexes (except for pertinent X-ray crystallography data) is reported in the SI (#1). 
B. Physical Measurements – Characterizations. 
NMR spectra were recorded at room temperature on a Anasazi-Varian 60 MHz FT spectrometer at 
Penn State Harrisburg, or a Bruker AC200 FT at UMass-Amherst, or a Bruker 500MHz FT 
spectrometer at Penn State Hershey Medical Center. Chemical shifts are reported in ppm relative to 
internal standard of TMS. FTIR data for solid samples (as KBr disks) and liquid samples (neat) were 
obtained on a Jasco 4000 or a Perkin Elmer 783 IR spectrometer. The IR spectral peaks were 
calibrated with polystyrene, and are reported in wavenumbers. Relative intensities of the bands in a 
spectrum are indicated (w = weak, m = medium, s = strong, vs = very strong, br = broad). Solid-state 
magnetic susceptibilities were obtained on Johnson Matthey (MK-1 and MSB-1) magnetic 
susceptibility Gouy balances. The Evans technique for measurement of solution magnetic moments 
was also employed,86,87 using coaxial NMR tubes. Electrospray mass spectrometry (ESI-MS and 
(MS)n) measurements were made at UMass using an Esquire LC/MS 32 instrument, or at Penn State 
using an Applied Biosystems API 150EX instrument. The m/z values are given to 4 significant 
figures. The reported m/z values in the synthetic section correspond to the most intense peak in the 
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isotopic cluster, the calculated & theoretical m/z values are based on isotopic masses (on the weight 
of the most common isotopes, monoisotopic mass). In some cases the ‘most intense peak’ value and 
the calculated ‘common isotope’ value may not necessarily be the same. Samples for ESI-MS analysis 
were introduced as MeOH/MeCN solutions, and routinely characterized in a combination of both 
positive and negative modes. Isotopic MS clusters were identified, and all those highlighted were 
found to be in accordance with their simulations. Selected simulated spectra and the regions that they 
represent in the original spectra are included in the SI. Spectra were simulated using various MS 
calculating software programs. Appropriate coupled MS/MS and (MS)n methods were utilized where 
necessary, and both the parent spectra and the fragmentation patterns were used to elucidate the 
reaction products. The experimental data indicate the successful preparation of the complexes 
mentioned. Elemental analyses were performed at the UMass-Amherst Microanalysis Center, and 
QTI, Whitehouse, NJ. Samples for microanalysis were ground to a fine powder and vacuum 
desiccated over phosphorus pentoxide prior to analysis. 
Single-crystal X-Ray crystallographic studies were performed in part by Dr. Carl Carrano and Mr. J. 
Hoffman at San Diego State University using a Bruker X8 Apex diffractometer (Complex 2), by Dr. 
H. Yennawar using a Bruker Apex SMART CCD diffractometer at Penn State University (Complex 
3, 8, 10), and by Dr. A. Chandrasekaran at UMass-Amherst using a Nonius Kappa CCD 
diffractometer (Complex 6). For each apparatus, a graphite monochromated Mo K radiation ( = 
0.71073Å) source was employed. Data were generally collected at 23 ± 2C, specific details are given 
in the SI. A θ-2θ scan mode was used for data collection from about 2° ≤ 2 θMo Kα ≤ 29°. The data 
were solved by a full matrix least squares refinement on F2 using the SHELX suite of programs.88 
The plotting program ORTEP-3 for Windows or CaChe-6 (Fujitsu Ltd, 2004) was used89 for the 
structural diagrams: 
Complex 2: The crystal used to solve complex 2 was a red colored plate (BSC1a) with approximate 
dimensions 0.2 x 0.2 x 0.02 mm3. A total of 10794 independent reflections were collected at 200K, 
and final refinement was based on 6246 observed reflections (I ≥ 2σi). Sum formula is NiC11H24N2S2. 
FW is 307.15. Crystals of 2 form in the monoclinic space group P21/n with cell dimensions a = 
10.5547(10) Å, b = 12.3943(11) Å, c = 11.5831(11) Å. α = γ = 90°, β = 111.126(5)°, and Z = 4. Rint 
= 0.087. The structure was refined to R = 4.40% and Rw = 10.22% (I > 2σ(I)). Pertinent 
crystallographic data is provided in Table 1. Details are provided in SI (#2). 
Complex 3: The crystal used to solve complex 3 was blue block (BTW5s) with approximate 
dimensions 0.21 x 0.32 x 0.37 mm3. A total of 7086 independent reflections were collected at 298K, 
and final refinement was based on XYZ centroids of 6974 reflections above 20 σ(I) with 
2.320°<θ<28.167°. Sum formula is NiC17H40I2N4O4S2. FW is 741.16. Crystals of 3 form in the 
triclinic space group P-1 with cell dimensions a = 10.4046(12)Å, b = 10.9123(12)Å, c = 
13.8838(16)Å, α = 87.671(2)°, β = 78.132(2)°, γ = 72.023(2)° and Z = 2. Rint = 0.013. The structure 
was refined to R = 4.90% and Rw = 13.86% (I > 2σ(I)). Pertinent crystallographic data is provided in 
Table 1. Details are provided in SI (#3). 
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Complex 6: The crystal used to solve complex 6 was a blue colored plate (BC39) with approximate 
dimensions 0.15 x 0.15 x 0.05 mm3. A total of 3113 independent reflections were collected at 293K, 
and final refinement was based on 2038 observed reflections (I ≥ 2σi). Sum formula is 
NiC13H28I2N4O2S2. FW is 649.02. Crystals of 6 form in the monoclinic space group P2(1)/n with cell 
dimensions a = 11.2811(9) Å, b = 12.8465(8) Å, c = 15.4674(13) Å. α = γ = 90°, β = 83.251(4)° and 
Z = 4. Rint = 0.1173. The structure was refined to R = 6.41% and Rw = 13.83% (I > 2σ(I)). Pertinent 
crystallographic data is provided in Table 1. Details are provided in SI (#4). 
Complex 8: The crystal used to solve complex 8 was blue-purple colored plates (BTW17o) with 
approximate dimensions 0.30 x 0.02 x 0.02 mm3. A total of 3752 independent reflections were 
collected at 298K, and final refinement was based on 3556 observed reflections (I ≥ 2σi). Sum formula 
is NiC10H19N2O12. FW is 417.96. Crystals of 8 form in the orthorhombic space group Pna2(1) with 
cell dimensions a = 14.669(5) Å, b = 16.306(5) Å, c = 7.034(2) Å. α = γ = β  = 90°, and Z = 4. Rint = 
0.029. Flack parameter = 0.047 (8). The structure was refined to R = 3.68% and Rw = 9.41% (I > 
2σ(I)). Pertinent crystallographic data is provided in Table 2. Details are provided in SI (#5). 
Complex 10: The crystal used to solve complex 10 was a red-pink colored plate (BSC1o) with 
approximate dimensions 0.01 x 0.12 x 0.22 mm3. A total of 1650 independent reflections were 
collected at 298K, and final refinement was based on XYZ centroids of 915 reflections above 20 σ(I) 
with 2.248°<θ<24.842°. Sum formula is NiC10H22N2S2. FW is 293.13. Crystals of 10 form in the 
orthorhombic space group Pbcn with cell dimensions a = 9.487(6) Å, b = 7.862(5) Å, c = 18.145(13) 
Å. α = β = γ = 90°, and Z = 4. Rint = 0.0863. The structure was refined to R = 6.32% and Rw = 14.51% 
(I > 2σ(I)). Pertinent crystallographic data is provided in Table 1. Details are provided in SI (#6). 
C. Physical Measurements - Quenching Experiments 
UV-visible absorbance measurements (UV-vis) were obtained on a HP 8453 Diode Array 
Spectrometer, or a Cary 4000 UV-vis Spectrophotometer. All experiments were performed at room 
temperature. The fluorescence emission spectra were obtained using a PE LS50B Spectrometer. 
Fluorescence spectra were normalized and then corrected for wavelength dependent sensitivity using 
a calibration curve generated using five spectral fluorescence standards (BAM-F001 to F005, Sigma-
Aldrich).90 For each series, the protein (or free Trp) concentration was held constant at 1.0 x 10-5 M 
and the concentration of each Ni(II) complex was varied (0.0 μM to 21.0 μM) through the preparation 
of individual samples. The excitation wavelength was 280 nm, emission wavelength was 345 nm and 
excitation and emission slit widths were 3.5 nm each. The dynamic quenching constants were 
determined using the Stern-Volmer equation 67,71: 
𝐹0
𝐹
= 1 + 𝐾𝑆𝑉[𝑄]                 (1) 
F0 and F correspond to the fluorescence intensities of the protein without quencher and in the presence 
of quencher, respectively. [Q] is the concentration of the quencher and KSV is the Stern-Volmer 
quenching constant. Also, KSV is related to the lifetime of the system according to equation 2 67: 
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𝐾𝑆𝑉 = 𝑘𝑞𝜏0                     (2) 
kq is the bimolecular quenching constant and 0 is the lifetime of unquenched fluorophore. 0 is short 
for Trp alone (2.7 ns) but longer in a protein environment (9.8 ns). 91-93 The static quenching constant, 
also known as the binding constant, Ka, and number of binding sites (n) between the protein and metal 
complexes were calculated using equation 3 67,94:  
 𝑙𝑜𝑔 [
𝐹0−𝐹
𝐹
] = 𝑙𝑜𝑔𝐾𝑎 + 𝑛𝑙𝑜𝑔[𝑄]               (3)  
The modified Stern-Volmer plot is useful when studying a protein that has Trp in different 
environments, for example buried residues versus residues at the surface, as is the case with both BSA 
and lysozyme.66,67 In such cases the Stern-Volmer plot will have a downward curve indicating that 
some of the fluorescence is not accessible. In this study, the modified Stern-Volmer analysis was not 
relevant as the complexes were quenching the proteins and free Trp via static quenching.  
RESULTS & DISCUSSION 
The series of small water soluble Ni(II) complexes (Figure 1) represents molecules that vary in charge 
(neutral, cationic, anionic), spin state  (low, high), and degree of hydrophilicity by virtue of the nature 
of ligands. 
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Figure 1. Ni(II) complexes used in this study, I. Ni-Pr-Et. II. Ni-Pr-Pr. III. Ni-Pr-Pr-Iodo. IV. 
Ni(pya2tn)Cl2·H2O. V. Ni-(en)2Cl2. VI. Ni-Pr-Et-Iodo. VII. Ni(pya2tn-OH)Cl2. VIII. Ni(EDTA)-H2O-Na IX. 
Ni-Et-Et. X. Ni-Et-Pr. XI. Ni(en)3Cl2.2H2O XII. Ni(NH3)6Cl2. [(Pr = propyl, Et = ethyl, en = ethylenediamine, 
tn = trimethylene diamine, EDTA = ethylenediaminetetraacetate, pya = Schiff base ligand derived from 
pyridine-2-carboxaldehyde and 1,3-diaminopropane (pya2tn)] 
 
A. Synthesis and Characterizations of the Nickel Complexes 
Complexes 1, 2, 9, and 10: These four Ni(II) compounds are cis diamino dithiolate square planar 
complexes. Sulfur containing ligands readily form [NiL2]2- type four coordinate complexes in the 
presence of large excess of dithiolato ligand (L2). At lower ligand concentrations, the propensity of 
thiolato-S to form bridges between metal centers gives rise to multinuclear species, an inconvenience 
that is also dependent on reaction conditions, such as temperature and protic solvent conditions.95,96 
One way to prevent such oligomerizations is to use bulky and/or aromatic substituents and/or chelate 
ligands that readily undergo template reactions. The latter method was used to synthesize four of the 
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complexes reported herein. The synthesis of each of the low spin neutral complexes 1, 2, 9, and 10 
are analogous (SI #1). Complexes 1 and 9 have been previously synthesized, and crystal structures 
reported.95,97,98 All characterization data, including ESI-MS spectra and elemental microanalysis are 
consistent with the formulations and structures given for each complex (see SI #1). Selected bond 
lengths and angles for 1, 2, 9, and 10 are given in Table 1. The molecular structures of each of these 
four complexes reveal discreet mononuclear units, with no intermolecular Ni-S interactions.  
Table 1: A comparison of selected bond lengths (Å) and bond angles () for complexes 1,97 6, 2, 3, 9,98 and 
10.  
 
 Bond Lengths (Å) 
              1                 6                2                3               9                10╘ 
 
Ni-S1             2.176(1)   2.407(4) 2.1605(3) 2.4406(12) 2.166(1)           2.1679(16)  
Ni-S2         2.174(1)   2.446(3) 2.1692(3) 2.4319(11) 2.173(1)           2.1679(16)  
Ni-N1         1.999(3)   2.098(10)           1.9888(9) 2.121(3)  1.931(4)           1.939(4) 
Ni-N2         2.006(3)   2.118(10)           1.9844(9) 2.128(4)  1.942(4)           1.939(4)  
Ni-O1     2.134(8)   2.042(3) 
Ni-O2     2.035)8)   2.063(3)  
Bond Angles ()           
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S1-Ni-S2       85.37(4)   96.00(12) 88.044(14) 91.32(4)  94.01(6)           96.18(9)  
S1-Ni-N1      89.31(9)   87.6(3)  88.72(3)  86.06(10) 89.9(1)           90.24(13) 
S1-Ni-N2      173.14(7)   102.5(3) 174.90(3) 177.61(10) 170.9(1)           163.74(11)  
S2-Ni-N1      172.28(9)     174.3(3) 175.00(3) 174.96(10) 170.3(1)           163.74(11)  
S2-Ni-N2      88.26(8)   86.7(3)  88.57(3)  86.30(10) 89.1(1)           90.24(13)  
N1-Ni-N2      97.3(1)   97.0(4)  95.77(4)  96.32(14) 88.3(2)           87.6(2)  
O1-Ni-S1      80.3(3)   89.69(10) 
O1-Ni-S2      83.8(2)   83.83(9)    
O2-Ni-S1      166.1(3)   82.06(9)    
O2-Ni-S2      83.6(2)   89.78(9)    
O2-Ni-N1     91.9(4)   94.12(13)    
O2-Ni-N2     91.4(4)   97.78(13)    
O2-Ni-O1     85.8(3)   169.46(12)   
N1-Ni-O1     92.4(4)   91.84(12)    
N2-Ni-O1     170.3(4)   90.19(13)   
╘ Equivalent atoms generated by symmetry transformations.  
 
Complex 197 and 998 have been previously studied by X-ray crystallography. Complex 2 (Figure 2) 
and 10 (Figure 3) are novel. A comparison of the crystal structures of 1 and 2, and that of 9 and 10 
show that there is very little difference in bond lengths and angles when a methyl group is placed on 
the carbon alpha to the thiolates. A slight opening of the S1-Ni-S1 angle and a slight closing of the 
N1-Ni-N2 angle is observed. The most striking difference between complexes 1 and 9 is in the N-
methyl groups: In 1 they are cis in configuration, (axial to the N1, N2, C3, C5 plane) whereas in 9 
they are trans (to the N1, N2, C4, C5 plane), a result of the steric requirements of a five-membered 
ring, and the tetrahedral requirement of the nitrogen atoms. The S-Ni-S bond angles in complex 1 and 
2 are more acute (by about 9) compared to the corresponding angles in complex 9 and 10. Conversely 
the N-Ni-N angle in complex 1 and 2 are more obtuse (by about 9) compared to the corresponding 
angles in 9 and 10. These angular differences would be expected given the smaller chelate bite angle 
of the ‘ethyl strap’ in complex 9.  
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Figure 2: ORTEP plot of complex 2, ellipsoids at 50% probability. The H atoms have been excluded for clarity. 
Full structural details are given in SI (#2).  
 
Figure 3: ORTEP plot of complex 10, ellipsoids at 50% probability. The H atoms have been excluded for 
clarity. Full structural details are given in SI (#6).  
Complexes 3 and 6: The alkylation of complex 1 or 2 with two equivalents of iodoacetamide gives 
complex 6 or 3, respectively (see SI #1). These alkylated complexes are high spin (S = 1) dications, 
blue to purple in color, with pseudo octahedral Ni(II) centers, each with a N2S2O2 donor ligand set, 
and iodide counterions. The iodoacetamide derivatives were readily crystallized (as beautiful gems) 
from MeOH/MeCN solutions and are very stable in the solid state. ORTEP plots of the crystal 
structures are shown in Figures 4 and 5.  
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Figure 4: ORTEP plot of complex 3, ellipsoids at 50% probability. The H atoms and the two iodide counterions 
have been excluded for clarity. Full structural details are given in SI (#3). 
 
Figure 5: ORTEP plot of complex 6, ellipsoids at 50% probability. The H atoms and the two iodide 
counterions, have been excluded for clarity. Full structural details are given in SI (#4). 
The most notable structural difference between the iodoacetamide derivatives is that complex 6 
contains Ni(II) with a cis-cis-cis geometrical N2S2O2 donor ligands, whereas complex 3 contains cis-
cis-trans geometry with the O’s being trans: These large atomic rearrangements, in going from 4 to 
6 coordinate avoids cis configuration of the N-methyl groups. The expansion of the coordination 
sphere also leads to expansion of all Ni-N and Ni-S bond lengths. The most pronounced is that for 
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the Ni-S bonds, which (on average) goes from 2.17 Å to 2.43 Å, this is similar to that observed by 
others in the literature for a similar Ni(II) environment.99 
Complexes 4 and 7: Both of these neutral high spin complexes were synthesized according to 
published procedures.100,101 These Schiff base complexes are hydrolytically stable over a wide pH 
range, due in part to the 5-6-5 membered chelate rings.100,102,103 The only significant difference 
between complexes 4 and 7 is the presence of a hydroxyl group on the second carbon of the NN’ 
propyl strap, it is expected that the additional feature will enhance the polar solubility of complex 7.  
Complexes 5, 11, and 12: The synthesis of each of these high spin Ni(II) amine/ammine complexes 
is well documented. Each of the complexes is very soluble in polar solvents, intensely colored, and 
make for an interesting comparison with the other complexes in this series. Complex 5 is neutral, and 
complexes 11 and 12 are dications in solution. 
Complex 8: The key role of the Ni(II) complex of EDTA in our studies is that it is anionic. The 
complex is stable and X-ray diffraction studies suggest that the complex in the solid state is a 
quinquedantate octahedral complex, with one non-complexed protonated acetate, and a water 
molecule bonded to the Ni. The structure, as shown in Figure 6, is similar to that reported in early 
literature,104 however some differences are noticeable [as would be expected 52 years later], and for 
that reason an updated crystal structure is presented here. A careful study of the packing relations 
between molecules strongly indicates that hydrogen bonding contributes significantly to the stability 
of the crystal. 
 
Figure 6: ORTEP plot of complex 8 monoanion, ellipsoids at 50% probability. The H atoms and the Na+ 
counterion, have been excluded for clarity. The ligand labeled O9 is water. Full structural details are given in 
SI (#4). 
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B. Fluorescence Quenching by Nickel complexes 
The fluorescence quenching observed in our studies is a result of the interaction between the ligand 
that is bound to the Ni complex, the Trp residue and its immediate vicinity in the protein. Table 2 
lists the Trp environment in the proteins studied. The extent of quenching observed varied with 
protein and with complex, and can be narrowed to some key factors: (i) the hydrophobicity of the 
ligand, (ii) presence or absence of complex charge, and (iii) the nature of the amino acids surrounding 
the Trp. While it has been reported in the literature that Ni ions can bind to BSA and form either 
square planar or octahedral complexes,28 the quenching observed is dependent on the nature of the 
ligand. 
Table 2: Trp environments in BSA, HSA and Lysozyme.105 Tyr residues are partially hydrophobic. 
 
      
 
Surrounding Amino Acid Residue(s) 
Protein 
Trp 
Residue(s) 
Positively 
Charged & 
amphipathic 
Negatively 
Charged 
Polar-
Uncharged 
Hydrophobic 
BSA 
Trp-134  -  Glu  Ser  Tyr, Val  
Trp-212  -  -  -  Tyr, Leu, Phe  
HSA Trp-214  -  -  -  Tyr, Val  
Lyso 
Trp-28  Lys  -  Asn, Thr  Val  
Trp-62,63  Arg  -  Ser   
Trp-108  -  -  Asn, Gln, Thr  Val  
Trp-111  Arg  Glu  Asn   
Trp-123  -  -  -  Ile 
 
A typical plot of Trp fluorescence quenching with increasing complex concentration is shown in 
Figure 7. In this case (BSA with complex 2), the fluorescence decreases by approximately 26% at 
the highest complex concentration used. The fluorescence quenching ranged from 0-56% in this study 
(Table 3), with the upper limit being slightly lower than the 60% quenching observed in our recently 
reported study with a Cr(III) complex.76  
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Figure 7: Fluorescence spectra of BSA (1.0 x 10-5 M) in the presence of different concentrations of complex 
2.  
Two common mechanisms for fluorescence quenching are dynamic quenching and static quenching. 
In order to determine the type of quenching taking place, two approaches are available and commonly 
used: The first involves a temperature-dependent study, as diffusion increases at higher temperatures, 
collisional quenching and subsequent dissociation of weakly bound complexes leads to a decrease in 
static quenching. In the second approach, as used in this work, the linearity of the Stern-Volmer plot 
is interpreted. The Stern-Volmer plot of F0/F against [Q] should be linear (equation 1), and this is 
usually the case for gas-phase and liquid-phase systems where either kq or 0 is large. In the case of 
the proteins and free Trp, 0 is small (10-8 to 10-9 s), which leads to Stern-Volmer plots that curve 
upwards.67,76 Sample plots for BSA quenching by complex 4 are given in Figure 8. The dynamic 
quenching plot (Figure 8B) is curving slightly upward even at low complex concentrations. The 
deviation from linearity is more prominent at higher complex concentrations as illustrated in the case 
of lysozyme and complex 4 (Figure 9). For static quenching, the binding constant (Ka) for the 
formation of an adduct between the Ni(II) complexes and BSA was determined using a double 
logarithmic plot (Figure 8A). The binding site values (n) were also determined from the slope using 
equation 3.  
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Figure 8: Stern-Volmer plots for (A) static quenching (R2 = 0.993) and (B) dynamic quenching of BSA by 
complex 4 (R2 = 0.9884). 
Figure 9: Dynamic quenching plot for lysozyme (1.0 x 10-5 M) quenching by complex 4. (A) The fluorescence 
of the protein is fully quenched when [4] approaches 120 μM. (B) Expansion of the enclosed area in A. 
Deviation from linearity is evident at complex concentration less than 21 μM. 
Another important consideration is that for dynamic quenching, the maximum value of kq is normally 
in the range of 2.0 x 1010 M-1s-1. 28,73,105  However, in this study, we found values of kq that are in the 
order of 1012 to 1013 M-1s-1, which are surprisingly consistent with our recent study involving a Cr(III) 
complex where a value of 1.8 x 1013 M-1s-1 was determined.76 These large Stern-Volmer constants 
strongly suggest that static quenching is predominant in these systems. Even though the evidence 
points towards static quenching, the KSV and kq values merit some discussion: The kq values provide 
a sensitive measure of the exposure of Trp residues in proteins. A low kq value indicates that the 
protein is sterically shielding the Trp from the solvent.13,67,74 In the systems we have studied, that 
clearly isn’t the case as the kq values are much greater. The kq values reported in this work are in good 
agreement with values reported in the literature for BSA-baicalin (~1.7 x 1013 M-1s-1), BSA-
kaempferol (~8.5 x 1012 M-1s-1) and BSA-[Cr(salprn)(H2O)2]+  (~1.9 x 1012 M-1s-1).13,74,106 
Fluorescence quenching is often a result of energy transfer from a donor (Trp) to an acceptor (metal 
complex).74 However, in all the systems and combinations studied, the quenching of Trp fluorescence 
is static and Forster’s long-range energy transfer is not taking place. Also, the spectral overlap 
between Trp emission and complex absorption is negligible (Figure 10) compared to other 
systems.45,72,73,76,106 The presence of an overlap between the emission band of the donor and the 
absorption band of the acceptor is a requirement for FRET. Therefore, the Ni(II) complexes are 
quenching the fluorescence via a thermodynamically favorable (G < 0) interaction with a high 
binding constant.  
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Figure 10: Overlap of Trp emission of 1.0 x 10-5 M Trp (solid line) with the absorption of 1.0 x 10-5 M complex 
1, showing negligible absorbance of the complex in the region of Trp fluorescence emission. 
C. Nature of the Interaction between the proteins and nickel complexes 
The proteins used in this study have complex structures and therefore many types of interactions are 
possible between the protein and a small complex or molecule. Van der Waals, electrostatic, 
hydrophobic and hydrogen bonding interactions are all possible.106 The resulting fluorescence 
quenching of Trp occurs only when there is interaction with the hydrophobic ligands, and the 
interaction is either promoted or stabilized by the surrounding amino acid residues (Table 2).  
The most noticeable correlation from data in Table 3 is that small neutral alkyl Ni(II) complexes (1, 
2, 9 and 10) quench fluorescence better than the bulky charged complexes, such as 3, 6, and 8. The 
spin state (high spin for the hexacoordinate, and low spin for the tetracoordinate complexes) appears 
to play little part in the interaction. The hexacoordinate complexes studied are for the most part 
charged, and only complexes 4, 5 and 7 are neutral. Of these three neutral complexes, 4 and 7 possess 
hydrophobic aromatic ligands and are amongst the strongest fluorescence quenchers. The significant 
decrease in quenching observed between BSA and lysozyme with complex 7 is due to hydrogen-
binding interactions resulting from the presence of an OH group in 7. The high binding constants (Ka) 
correlate with the negative values obtained for G, confirming that binding is spontaneous. Similar 
values have been observed in other studies involving BSA, HSA and lysozyme.45,46,72,73,76,106-108 The 
H value is zero for hydrophobic interactions, and so S is positive. G values range from -5 to -40 
kJ mol-1 when one binding site is involved (n = 1), and previous studies76 have yielded values in the 
15 to 35 kJ mol-1 range. When more than one binding site is involved, the association is even more 
thermodynamically favorable, with G from -40 to -60 kJ mol-1. 
Table 3: Percent decrease in fluorescence intensity of fluorophore (1.0 x 10-5 M) after addition of highest 
amount of quencher (21 μM). 
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Protein Nickel Complexes 
 1 2 3 4 5 6 7 8 9 10 11 12 
BSA 17.2 26.3 No 49.4 No No No No 43.4 31.3 No No 
HSA 20.3 23.7 13.0 54.5 No No 40.6 No 48.3 28.4 No No 
Lyso 17.2 21.1 No 55.6 No No 19.3 No 43.3 41.3 No No 
Trp 22.1 No No 55.9 No No 36.5 No 48.0 42.0 No No 
Charge on 
Complex  
0 0 +2 0 0 +2 0 -1 0 0 +2 +2 
 
i. BSA and HSA: Both serum albumin proteins were quenched by complexes 1, 2, 9 and 10. These 
complexes are similar in structure, with what appear to be subtle differences. The binding constants, 
Ka, for these four complexes were on the order of 103 and higher. The fluorescence quenching by 
complex 9 was the greatest in this group (Table 3, 43% for BSA and 48% for HSA) and the Ka values 
were as high as 107, indicating strong binding by this particular complex to the Trp region of the 
proteins (Table 4). Complex 9, with its 5-5-5 membered chelate rings, is slightly smaller than 
complexes 1, 2 and 10 thereby lending itself to a slightly stronger interaction with the protein. The 
quenching by the slightly larger complex 10 was significantly lower at 30%, with Ka values on the 
order of 104-105. For complex 2, the quenching was about 25% in both cases, and the Ka values were 
on the order of 104 to 105. A correlation between complex size and the ability to quench and bind 
strongly is evident.  
 
 
 
Table 4: Summary of binding constant, Ka, binding site number, n, and G for BSA and HSA. 
  
Complex BSA HSA 
 Ka, M-1 n G, kJ mol-1 Ka, M-1 n G, kJ mol-1 
1 3.2 x 104 1 -26 5.7 x 109 2 -56 
2 2.7 x 105 1 -31 1.4 x 104 1 -24 
3 - - - 9.1 x 104 1 -28 
4 3.2 x 105 1 -31 2.2 x 105 1 -30 
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5 - - - - - - 
7 - - - 1.8 x 105 1 -30 
9 3.8 x 107 1.5 -43 1.3 x 107 1.5 -41 
10 5.8 x 105 1 -33 2.4 x 104 1 -25 
 
A close examination of the immediate environment of each Trp (Table 2) indicates that there is at 
least one hydrophobic or partially hydrophobic or amphiphilic amino acid in the immediate vicinity. 
In both BSA and HSA, the partially hydrophobic Tyr is buried in the hydrophobic core. Hydrophobic 
amino acids such as Leu and Val are capable of recognizing and binding hydrophobic ligands. The 
Tyr residue is also capable of interacting with ligands via stacking interactions, which appears to be 
the nature of the interaction with the pyridinium rings in complexes 4 and 7. In the case of complex 
4, the fluorescence quenching is the greatest (> 49 %) and the binding constants are on the order of 
105. Interestingly, HSA showed a strong association with complex 7 (Ka ~105) but BSA did not. The 
ligand in complex 7 differs from complex 4 in only one regard, it contains an OH group. Trp-134 in 
BSA has a polar amino acid (Ser) in its vicinity and so it is possible that H-bonding interaction occurs 
between this residue and complex 7, in addition to the H-bonding involving Trp. The H-bonding 
interaction is stronger than any stacking interaction that would be expected between Tyr (or Trp) and 
the pyridinium group(s) in the complex. The H-bonding between the OH group in the complex and 
the Ser (and/or Trp) residue is also stronger than hydrophobic interactions promoted by the Leu and 
Val residues that are in the vicinity of Trp-134. This rationale explains the absence of fluorescence 
quenching and absence of binding of complex 7 to BSA. On the other hand, HSA does not have a 
polar amino acid near its Trp-214 so the hydrophobic interactions predominate, leading to 
fluorescence quenching. 
HSA weakly interacts with the neutral complexes 1 and 2 (about 20% quenching), very weakly with 
the cationic complex 3 (13% quenching), and not at all with complex 6. These weak or non-existent 
interactions with 3 and 6 are most likely due to the presence of NH2 groups in the respective ligands, 
the interaction with Trp-214, and the influence of the nearby tyrosine residues in HSA. Once again, 
H-bonding is possible between the NH2 groups and the amino acids. No interaction was detected for 
3 and 6 with BSA due to the presence of more hydrophobic groups, and of course the lower 
hydrophobicity of the ligands in these complexes.  
No fluorescence quenching was observed for any proteins with complexes 11 and 12. The ligands on 
complexes 11 and 12 are strongly hydrophilic, and therefore not exhibiting the type of interaction that 
would lead to quenching of protein fluorescence. In general, interaction between complexes and 
proteins occurred only with complexes containing hydrophobic ligands. This observation underscores 
the nature of the Trp residue, and the importance of the immediate vicinity being occupied by one or 
more hydrophobic residues, or at least partially hydrophobic amino acid residues. 
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ii. Lysozyme: Lysozyme fluorescence was quenched by complexes 1, 2, 4, 7, 9 and 10. These are all 
neutral complexes, with hydrophobic ligands. Significant quenching was observed with complex 4. 
Given that lysozyme has six Trp residues, a variety of interactions are possible between the protein 
and the Ni(II) complexes. Trp-28, Trp-62, Trp-63 and Trp-111 are close to amphiphilic amino acids 
like Lys and Arg, while Trp-108 and Trp-123 are close to hydrophobic Val and Ile, respectively. The 
hydrophobic interactions are the most important. In terms of binding constants, the interaction 
between lysozyme and complex 4 was exceptionally strong while the interaction with 7 was the 
weakest (Table 5). The ligand in complex 7 differs from 4 in only one regard in that it contains an 
OH group, which leads to a disruption in binding and quenching. There was no change in fluorescence 
intensity when 3.0 μM of complex 4 was added but further addition of the complex resulted in 
significant static quenching over the 3.0 to 21 μM range (Figure 9). The high fluorescence quenching 
resulted in a higher than average binding constant (~1010) and a binding site number of 2.  
Table 5: Summary of binding constant, Ka, binding site number, n, and G for lysozyme and free Trp. 
  
Complex Lysozyme Free Trp 
 Ka, M-1 n G, kJ mol-1 Ka, M-1 n G, kJ mol-1 
1 6.7 x 107 2 -45 1.4 x 103 1 -18 
2 5.1 x 107 2 -44 - - - 
4 1.6 x 1010 2 -58 2.0 x 105 1 -30 
7 - - - 4.6 x 102 1 -15 
9 5.4 x 106 1.5 -38 9.8 x 104 1 -28 
10 2.8 x 105 1 -31 2.4 x 105 1 -31 
iii. Free tryptophan:  Free Trp showed very similar behavior towards the Ni(II) complexes as the 
three proteins. The interaction was strongest with neutral complexes 1, 4, 7, 9 and 10 (Table 5). The 
absence of quenching with complex 2 is anomalous, and could be attributed to the steric effects 
resulting from the slightly larger size of the ligand when compared to the alkyl ligands in complexes 
1, 9 and 10. The interaction with 7 is significantly weaker due to the presence of the OH group on the 
ligand in the complex. This observation opens up the possibility of non-hydrophobic interactions 
taking precedence over hydrophobic interactions between the Trp and the pyridinium groups in the 
complex. This is similar to what was observed with BSA where there was no interaction with 7, but 
a strong interaction with 4. 
Our data suggests that in most of the systems studied, one binding site is present in each, the 
exceptions include all the interactions with lysozyme (except with complex 10), HSA with complex 
1 (n = 2), HSA with complex 9 (n = 1.5), and BSA with complex 9 (n = 1.5). A binding site number 
of 1 is typical when static quenching of proteins occurs as a result of hydrophobic interactions with 
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transition metal complexes and other molecules. The presence of two binding sites in lysozyme is not 
unusual as there are six Trp residues in the protein, and complex 4 can associate with the different 
Trp residues via stacking interactions through the pyridinium groups. The small size of complexes 1, 
2 and 9 is also an important factor, allowing for these complexes to squeeze in to additional bindings 
sites. Complex 9 is the smallest of these complexes, and is found to be binding more strongly to both 
BSA and HSA compared to any of the other complexes, therefore a higher binding site number is not 
unexpected. BSA has two and HSA has only one Trp residue, and so the presence of two binding sites 
in HSA raises the possibility that multiple small quencher molecules may be involved since they 
would have easy access to the Trp residue via hydrophobic interactions.  
Quantum chemical computational studies using ab initio methods (Gaussian09) are currently 
underway to determine the energetic contribution of the interactions between the Trp residues and the 
surrounding amino acids in HSA, BSA, and lysozyme, with these Ni(II) complexes.  
 
CONCLUSIONS 
We have synthesized and fully characterized a series of Ni(II) complexes. Fluorescence quenching 
studies with albumins and lysozyme proteins clearly suggests that the Ni(II) complexes featuring 
hydrophobic ligands exhibit strong and favorable interactions. These  interactions takes place between 
the hydrophobic pocket of the protein and the ligand. The poorest interactions are with charged bulky 
Ni(II) complexes. Static quenching was found to be the predominant form of quenching taking place 
in these systems, and generates high binding constants. The small neutral square planar Ni(II) 
complexes (1, 2, 9 and 10) and the neutral aromatic complexes (4 and 7) are currently being studied 
as possible DNA intercalators and quadruplex DNA promoters.  
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